Aleah Brubaker

MD, PhD
Transplant and Hepatobiliary Surgeon, Assistant Professor of Surgery
UC San Diego
Aleah Brubaker

Brief Bio

Aleah Brubaker, MD, PhD, is a board-certified surgeon who specializes in abdominal (liver and kidney) transplantation in adult and pediatric patients. She also has expertise in surgical treatment of liver tumors, hepatocellular carcinoma, liver cirrhosis and end-stage renal disease.

As an assistant professor in the Department of Surgery, she trains medical students, residents and fellows at UC San Diego School of Medicine. Dr. Brubaker’s research interests include transplantation and the human microbiome.

Her work has appeared in medical and research publications, including Transplantation and Clinical Transplantation. Dr. Brubaker has co-authored several book chapters on transplantation. She also has presented her work on transplant outcomes and pediatric transplants at various national meetings.

Dr. Brubaker completed a fellowship in transplant surgery at Stanford Health Care in Stanford, Calif., where she also did her residency in general surgery. She holds both a medical and doctorate degree from the Loyola University Medical Center in Maywood, Ill. She is board certified in general surgery.

Dr. Brubaker is a member of the American Society of Transplant Surgeons and the American College of Surgeons.

In her free time, Dr. Brubaker enjoys hiking, swimming, skiing and cooking.

Alliance Presentations

Close Up Of Surgery Team Operating

Setting Up an NRP Program: From Ethics to Education

Tuesday, October 17, 2023, at 2:00pm

The Alliance Conversation Series brings you cost-free, fast-paced collaborative opportunities that highlight successful donation and transplantation practices across the country. Through shared insight, multidisciplinary experts identify solutions to critical challenges affecting the community of practice and actively share them for open discussion and broader knowledge of effective practices.

The sessions encourage real-time feedback and participation from viewers.

Overview: The use of NRP during DCD organ recovery leads to increased organ utilization and improved transplant outcomes compared with conventional organ recovery. Artificial circulation through a mechanical circulatory device (ECMO) is initiated to perfuse the organs during recovery. This technique allows for the assessment of organ function and viability for subsequent transplantation. The overall advantage of NRP is that organs previously not utilized can now be utilized for transplantation, allowing for improved stewardship of the gift from the donor and their family and providing hope for those in need of a life-saving transplant.
As with many new approaches or procedures in medicine, NRP comes with legal and ethical considerations, clinical considerations, as well as operational considerations. In this session, you will hear from industry experts as we explore the challenges and successful strategies learned during the process of setting up an NRP Organ Recovery Program.

Our panel discussion will include:

  • How do you talk to/work with your hospital Ethics team in understanding NRP?
  • What research and supportive industry statements are available to reference?
  • What is being done to standardize the TA-NRP recovery process in the industry?
  • What are the outcomes and potential allocation impact considerations of NRP?
  • What steps can be taken to ensure communication and collaboration in preparation for NRP?

Lifelong Networks

Our partners are the heart and soul of our organization. For more than 15 years, they have played a vital role providing quality education and programs to advance a shared mission.